APA (7th ed.) Citation

MJ, K., SB, L., J, H., JE, L., JW, L., G, G., . . . YK, S. (2018). BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. PloS one, 13(11), e0207155. https://doi.org/10.1371/journal.pone.0207155

Chicago Style (17th ed.) Citation

MJ, Kwon, et al. "BCT Score Predicts Chemotherapy Benefit in Asian Patients with Hormone Receptor-positive, HER2-negative, Lymph Node-negative Breast Cancer." PloS One 13, no. 11 (2018): e0207155. https://doi.org/10.1371/journal.pone.0207155.

MLA (9th ed.) Citation

MJ, Kwon, et al. "BCT Score Predicts Chemotherapy Benefit in Asian Patients with Hormone Receptor-positive, HER2-negative, Lymph Node-negative Breast Cancer." PloS One, vol. 13, no. 11, 2018, p. e0207155, https://doi.org/10.1371/journal.pone.0207155.